Arvelle Therapeutics
Signal active
Organization
Contact Information
Overview
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders.
About
Industries
Biotechnology
Founded
2019
Employees
1-10
Headquarters locations
Switzerland, Europe
Social
N/A
Profile Resume
Arvelle Therapeutics headquartered in Switzerland, Europe, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $1.8B in funding across 8 round(s). With a team of 1-10 employees, Arvelle Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Arvelle Therapeutics, raised $42.7M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
7
Lead Investors
0
Total Funding Amount
$221.8M
Details
2
Arvelle Therapeutics has raised a total of $221.8M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 179.1M | ||
| 2020 | Early Stage Venture | 42.7M |
Investors
Arvelle Therapeutics is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| H.I.G. BioHealth Partners | - | FUNDING ROUND - H.I.G. BioHealth Partners | 42.7M |
| KB Investment | - | FUNDING ROUND - KB Investment | 42.7M |
| Arvelle Therapeutics | - | FUNDING ROUND - Arvelle Therapeutics | 42.7M |
| EQT Life Sciences | - | FUNDING ROUND - EQT Life Sciences | 42.7M |
Recent Activity
There is no recent news or activity for this profile.